However, high LAMP2 expression levels can predict the worst outcome in M1 BC patients (progression-free survival: p = 0.0005, 3.5 versus 23.73 months, log-rank test; overall survival: p = 0.05, log-rank test) (Fig. 4, A and B). This evidence concerns the gene LAMP2 and breast cancer.